Recruitment

Recruitment Status
Unknown status

Inclusion Criteria

Informed consent
Pathological rectosigmoid carcinoma
Tumor size of 5 cm or less; 6) ECOG score is 0-1
...
Informed consent
Pathological rectosigmoid carcinoma
Tumor size of 5 cm or less; 6) ECOG score is 0-1
Preoperative T stage ranging from T1 to T4a according to the 7th Edition of AJCC Cancer Staging Manual
ASA socre is Ⅰ-Ⅲ
18 years < age < 80 years
Tumor located in rectosigmoid (defined as 10- to 30-cm from the anal verge)

Exclusion Criteria

Previous abdominal surgery
Severe mental disease
Pregnant woman or lactating woman
...
Previous abdominal surgery
Severe mental disease
Pregnant woman or lactating woman
Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer
Body mass index (BMI) >30 kg/m2
Requirement of simultaneous surgery for other disease

Summary

Conditions
Colorectal Cancer
Type
Interventional
Phase
Phase 2
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Inclusion Criteria

Informed consent
Pathological rectosigmoid carcinoma
Tumor size of 5 cm or less; 6) ECOG score is 0-1
...
Informed consent
Pathological rectosigmoid carcinoma
Tumor size of 5 cm or less; 6) ECOG score is 0-1
Preoperative T stage ranging from T1 to T4a according to the 7th Edition of AJCC Cancer Staging Manual
ASA socre is Ⅰ-Ⅲ
18 years < age < 80 years
Tumor located in rectosigmoid (defined as 10- to 30-cm from the anal verge)

Exclusion Criteria

Previous abdominal surgery
Severe mental disease
Pregnant woman or lactating woman
...
Previous abdominal surgery
Severe mental disease
Pregnant woman or lactating woman
Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer
Body mass index (BMI) >30 kg/m2
Requirement of simultaneous surgery for other disease

Tracking Information

NCT #
NCT02117557
Collaborators
Not Provided
Investigators
  • Principal Investigator: Guoxin Li, M.D., PH.D. Nanfang Hospital, Southern Medical University, China
  • Guoxin Li, M.D., PH.D. Nanfang Hospital, Southern Medical University, China